Aline R. Pavan

Araraquara, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Epigenetic strategies for fetal hemoglobin induction in sickle cell disease.

Epigenetic strategies for fetal hemoglobin induction in sickle cell disease.

Journal: European journal of medicinal chemistry

Published: May 08, 2026

In vitro and In vivo Activity of a New N-Oxide Derivative for Acne Vulgaris Treatment.

In vitro and In vivo Activity of a New N-Oxide Derivative for Acne Vulgaris Treatment.

Journal: Medicinal chemistry (Shariqah (United Arab Emirates))

Published: April 03, 2024

In silico drug design strategies for discovering novel tuberculosis therapeutics.

In silico drug design strategies for discovering novel tuberculosis therapeutics.

Journal: Expert opinion on drug discovery

Published: February 20, 2024

Endothelial dysfunction in Sickle Cell Disease: Strategies for the treatment.

Endothelial dysfunction in Sickle Cell Disease: Strategies for the treatment.

Journal: Nitric oxide : biology and chemistry

Published: February 15, 2024

BacPROTACs targeting Clp protease: a promising strategy for anti-mycobacterial drug discovery.

BacPROTACs targeting Clp protease: a promising strategy for anti-mycobacterial drug discovery.

Journal: Frontiers in chemistry

Published: December 19, 2023

The state of the art of fetal hemoglobin-inducing agents.

The state of the art of fetal hemoglobin-inducing agents.

Journal: Expert opinion on drug discovery

Published: October 27, 2022

Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors.

Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: August 23, 2022

Perspectives and challenges to discovering hemoglobin-inducing agents in Sickle Cell Disease.

Perspectives and challenges to discovering hemoglobin-inducing agents in Sickle Cell Disease.

Journal: Frontiers in medicine

Published: July 24, 2022

Vascular Effects of the Fetal Hemoglobin Inducer Agent 3-(1,3-Dioxoisoindolin-2-yl) Benzyl Nitrate.

Vascular Effects of the Fetal Hemoglobin Inducer Agent 3-(1,3-Dioxoisoindolin-2-yl) Benzyl Nitrate.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 11, 2022

Benzofuroxan Derivatives as Potent Agents against Multidrug-Resistant Mycobacterium tuberculosis.

Benzofuroxan Derivatives as Potent Agents against Multidrug-Resistant Mycobacterium tuberculosis.

Journal: ChemMedChem

Published: November 18, 2020

Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus.

Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus.

Journal: Frontiers in cell and developmental biology

Published: August 08, 2020

Synthesis and evaluation of resveratrol derivatives as fetal hemoglobin inducers.

Synthesis and evaluation of resveratrol derivatives as fetal hemoglobin inducers.

Journal: Bioorganic chemistry

Published: April 12, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026